Oventus Medical Ltd. | Income Statement

Fiscal year is July-June. All values AUD Thousands.
2015
2016
2017
2018
Sales/Revenue
56.30
540.20
448.00
271.30
Cost of Goods Sold (COGS) incl. D&A
115.40
1,743.30
3,767.20
3,725.60
Gross Income
59.10
1,203.20
3,319.20
3,454.30
SG&A Expense
122.10
953.60
2,974.40
2,698.40
EBIT
181.20
2,156.80
6,293.60
6,152.70
Non Operating Income/Expense
-
197.20
305.20
91.00
Pretax Income
180.60
2,341.10
6,510.10
5,870.50
Consolidated Net Income
180.60
2,341.10
6,510.10
5,870.50
Net Income
180.60
2,341.10
6,510.10
5,870.50
Net Income After Extraordinaries
180.60
2,341.10
6,510.10
5,870.50
Net Income Available to Common
180.60
2,341.10
6,510.10
5,870.50
EPS (Basic)
0.00
0.03
0.09
0.06
Basic Shares Outstanding
72,000.00
72,000.00
70,914.80
99,126.20
EPS (Diluted)
0.00
0.03
0.09
0.06
Diluted Shares Outstanding
72,000.00
72,000.00
70,914.80
99,126.20
EBITDA
174.70
1,959.30
5,678.00
5,395.10
Non-Operating Interest Income
0.60
12.90
88.70
191.20

About Oventus Medical

View Profile
Address
1 Swann Road
Indooroopilly Queensland (QLD) 4068
Australia
Employees -
Website http://www.oventus.com.au
Updated 07/08/2019
Oventus Medical Ltd. develops oral appliances for the treatment of obstructive sleep disordered and snoring. It offers an oral device under the O2Vent brand. The O2Vent unique design directs the air flow through to the back of the throat, alleviating multiple sites of obstruction including the nose, soft palate and tongue The company was founded by Christopher Patrick Hart in 2012 and is headquartered in Indooroopilly, Australia.